ARCHIVES

Phase III Trial Would Give Clearer Picture of C225 Role

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

SWOG Releases RFA For Use Of Biorepository

November 12, 2010

Et2’s Referral Guidelines

July 23, 1993

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

January 11, 2002

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

In Brief: Candlelight Vigil At Lincoln Memorial Planned For Night Before Cancer March

March 6, 1998

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982